Skip to main content
Clinical Trials/KCT0006970
KCT0006970Not yet recruiting未知

The analgesic efficacy and safety of nefopam in patient-controlled analgesia after breast reconstruction surgery: A randomized, double-blind, non-inferiority study

The Catholic University of Korea, Seoul St. Mary's Hospital0 sites120 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
20?(Year) to 75?(Year) (—)
Sex
Female

Inclusion Criteria

  • 1) age over 20 and under 75 years old female patients
  • 2) patients scheduled to undergo breast cancer resection surgery with immediate reconstruction
  • 3) ASA physical status I-III

Exclusion Criteria

  • 1) History of drug abuse
  • 2) Chronic pain that requires continuous administration of opioids
  • 3) History of seizure or mental illness
  • 4) Bradycardia (Heart rate < 50 beats per minute) or arrhythmia
  • 5) Cardiovascular diseases(coronary artery disease, ischemic heart disease, etc.) other than diabetes and hypertension
  • 6) Moderate to severe renal of hepatic disease
  • 7) Pregnant or breast feeding patients
  • 8) History of allergy to study drugs
  • 9) Fail to give informed consent

Investigators

Similar Trials